We are live on
!
Find out more
CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
23 hedge funds and large institutions have $20.9M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$456K | |
| 2 | +$418K | |
| 3 | +$397K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$84.4K |
| 5 |
OC
Oppenheimer & Co
New York
|
+$44.2K |
Top Sellers
| 1 | -$2.1M | |
| 2 | -$930K | |
| 3 | -$383K | |
| 4 |
CIA
Choate Investment Advisors
Boston,
Massachusetts
|
-$224K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$86.9K |